Intravenous Use Articles & Analysis

1 news found

Diffusion Pharmaceuticals to Present at H.C. Wainwright BioConnect, Participate in Biotech Showcase and Bio Partnering at JPM during “J.P. Morgan Week 2022”

Cobuzzi also will describe certain aspects of the Company’s rationale for its plans to design and execute a clinical program to support the use of intravenously administered TSC as an adjunctive treatment for hypoxic solid tumors. ...

Dec. 7, 2021

ByCervoMed

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you